PPHF-2015-Enhanced Surveillance for New Vaccine Preventable Disease - A Program Expansion for Acute

Post Date

March 24th 2015

Application Due Date

May 26th 2015

Funding Opportunity Number

RFA-IP-11-0100501PPHF15

CFDA Number(s)

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

7

Eligibility Categories

Other

The following organizations are eligible to apply: Vanderbilt University School of Medicine, Nashville, TN University of Rochester School of Medicine and Dentistry, Rochester, NY Cincinnati Children's Hospital Medical Center, Cincinnati, OH Texas Children's Hospital, Houston, TX Seattle Children's Hospital, Seattle, WA Children's Mercy Hospital and Clinics, Kansas City, MO Children's Hospital and Research Center, Oakland, CA

Funding

• Estimated Total Funding:

  $3500000

• Award Range:

  $0 - $0

Grant Description

The main purpose of this supplemental funding announcement is to support a network of US institutions to assess influenza VE in preventing laboratory-confirmed influenza infections among hospitalized children aged <18 years. A second purpose of the supplement is to establish an inpatient surveillance network for surveillance of important non-influenza viral pathogens associated with pediatric acute respiratory illness, including RSV and EV-D68, among children aged <5 years.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  Technical Information Management Section (TIMS)
  2960 Brandywine Road
  Atlanta, GA 30341
  Office phone: 770-488-2700
  Fax: 770-488-8350
  

• Agency Mailing Address:

  PGOTIM@cdc.gov

• Agency Email Address:

  PGOTIM@cdc.gov

• Location:

  Centers for Disease Control and Prevention